This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing the Positive Topline Results from Two Pivotal Phase 3 Studies of TrenibotulinumtoxinE (BoNT/E) for the Treatment of Glabellar Lines
Ticker(s): AGNWho's the expert?
Institution: Tim Sayed MD
- Board-certified plastic surgeon with deep domain expertise and aesthetics including injectables, breast and body contouring, and facelifts.
- 10 botox injections a week for patients with glabellar lines
- Familiar with Daxxify(DaxibotulinumtoxinA-lanm) and the Phase 3 SAKURA study which led to its recent approval
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
